News from decision resources group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 05, 2017, 08:50 ET Interactive vaccines tool, a game-changer for developers, sizes any global market in under two minutes

Decision Resources Group (DRG) has developed a powerful, interactive tool that enables vaccine developers to test the potential of a product in any...


Nov 28, 2017, 08:20 ET Decision Resources Group Projects Explosive Growth of the Alzheimer's Disease Market if Emerging Agents Can Beat the Odds and Deliver Phase III Success

Decision Resources Group (DRG) announces the publication of its latest forecast for Alzheimer's disease (AD) pharmacotherapies, and projects that...


Nov 27, 2017, 07:45 ET Advanced epidemiology model helps HCV brands prepare for global market expansion

Decision Resources Group (DRG) has announced the introduction of a groundbreaking epidemiology product, addressing an urgent unmet need in the...


Nov 16, 2017, 13:33 ET Americans are beginning to call on "Dr. Siri" (and "colleagues") when health needs arise

AI-powered technologies such as voice search, voice assistants and chatbots are beginning to impact how patients and caregivers find info about...


Nov 13, 2017, 07:30 ET Solving the Treatment Sequencing Puzzle for Oncology Brands

Decision Resources Group (DRG) has announced the launch of an innovative product that allows oncology companies to make better-informed commercial...


Nov 10, 2017, 08:15 ET Rising Competition for Treating Positive Symptoms of Schizophrenia Requires Companies to Focus on Therapies for Negative and Cognitive Symptoms

Decision Resources Group finds that the schizophrenia market will decline from $6.1 billion in 2016 to $5.1 billion in 2026. This decline will be due ...


Nov 09, 2017, 08:15 ET DRG Publishes New Type 1 Diabetes Content; Forecasted Displacement Of Branded Insulins With Biosimilars, Increase In Treatment Options With Fiasp And SGLT Inhibitor Adjuncts To Insulin.

Decision Resources Group forecasts the type 1 diabetes (T1D) G7 market to reach $3.9 billion by 2026, with substantial sales growth forecast across...


Nov 07, 2017, 08:15 ET Decision Resources Group Projects G7 Sales Of The Multiple Sclerosis Market To Exceed $25 Billion In The Next Decade

Decision Resources Group (DRG) finds that ex-manufacturer sales for multiple sclerosis (MS) disease-modifying therapies (DMTs) will grow 2% annually...


Nov 06, 2017, 09:47 ET DRG Expects the Renal Anemia Market to Reach More than $6 Billion in 2026 Driven By the Emergence of the Novel HIF-PH Inhibitors

Decision Resources Group finds that the renal anemia market will experience growth within the G7 countries during 2016 – 2026. This growth will be...


Oct 30, 2017, 08:15 ET Groundbreaking use of real world data offers deep, monthly analysis of the explosion in immune checkpoint inhibitors

Decision Resources Group (DRG) has launched an innovative, new product that harnesses the power of real world data (RWD) to provide oncology...


Oct 24, 2017, 14:00 ET Longitudinal claims data makes Treatment Algorithms the gold standard for understanding brand performance by line of therapy

Biopharmaceutical commercial teams are benefitting from an exciting array of data-driven insights, revealing precise prescribing patterns and...


Oct 24, 2017, 08:38 ET DRG launches Patient Profiler, dramatically advancing the understanding of patient-level drivers in rheumatoid arthritis

Decision Resources Group (DRG) has launched a groundbreaking study that uses multiple sources of real world data (RWD) to provide disease-specific,...


Oct 10, 2017, 11:52 ET Pharma's approach to market access facing digital disruption, study finds

The pharmaceutical industry's traditional approach to market access is failing to meet the information needs of formulary decision makers heavily...


Oct 06, 2017, 08:30 ET DRG Expects the Pancreatic Cancer Market to Grow at an annual rate of 10% over the next 10 years to Reach Almost $4 Billion in 2026

Decision Resources Group finds that the pancreatic cancer market will grow from $1.3 billion in 2016 to $3.7 billion in 2026. This growth will be...


Sep 07, 2017, 16:06 ET The Launch of First-in-Class Biologic Therapies Will Drive Significant Growth Within the Osteoarthritic Pain Market Through 2026

Decision Resources Group finds that the launch of novel biologic therapies targeting nerve growth factor (NGF) will be the main driver of growth in...


Aug 22, 2017, 08:22 ET The Gastroesophageal Cancer Market is Expected to Grow Sevenfold Over the Next Ten Years Capturing $13 Billion in 2026

Decision Resources Group finds that the gastroesophageal cancer market will grow significantly from almost $2 billion in 2016 to $13 billion in 2026, ...


Aug 16, 2017, 10:22 ET DRG's Formulary Insights Sheds Light on Dangers, Opportunities Related to Formulary Trends

Decision Resources Group (DRG), leading provider of healthcare market intelligence, has launched a research initiative that dives into the dynamics...


Aug 16, 2017, 09:00 ET Decision Resources Group Acquires Context Matters to Expand Global Market Access Intelligence Offerings

Decision Resources Group (DRG), the life sciences industry's most trusted provider of market intelligence and global data products and services,...


Aug 14, 2017, 14:23 ET Decision Resources Group Rates Advancement of Influential IDNs

Leading provider of healthcare research and analytics, Decision Resources Group (DRG), has introduced a new methodology for analyzing and segmenting...


Aug 14, 2017, 13:41 ET DRG Gauges Impact of Managed Care Dynamics on Medical Device Industry at a Local Level

Decision Resources Group, premier provider of healthcare market intelligence, recently announced the addition of a new module to its Market Overviews ...


Aug 08, 2017, 12:10 ET Survey of Payers and Gastroenterologists Finds Excitement Over the Prospect of JAK Inhibitors to Treat Inflammatory Bowel Disease

Decision Resources Group finds that surveyed health insurance medical and pharmacy directors as well as gastroenterologists look favorably on Janus...


Aug 01, 2017, 13:09 ET Emerging Immune Checkpoint Inhibitors May Find the Road to Optimal Market Access Rocky

Decision Resources Group finds that, despite mixed fortunes in health technology assessment (HTA) across the EU5 (France, Germany, Italy, Spain, and...


Aug 01, 2017, 12:30 ET Doctors say pharma rep details are stale, need updating for digital age

Despite the pharma sales force making great strides towards "digitizing the field" with tablets and other technologies – a new study from DRG...


Jul 19, 2017, 09:22 ET Eylea Will Dominate The Wet Age-Related Macular Degeneration Market Until 2018, When Its Share Will Become Threatened By Emerging Products

Decision Resources Group finds that over the next ten years, the market for late age-related macular degeneration (AMD) therapies will become...


Jun 28, 2017, 10:42 ET With Launch of Generic Inhaled Therapies for Asthma and COPD, Devices will Allow Some Drugs to Stand Out

Decision Resources Group finds that practitioners prescribing inhaled therapies prefer simpler devices. Although the diverse array of drug/device...